Can Centene's Fraud Prevention Strategy Support Margin Recovery?
CNC expands AI-driven fraud prevention and payment integrity to improve Medicaid margins, boost cost controls and support long-term earnings growth.
CNC - Centene Corp.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$61.00
DETAILS
HIGH:
$80.00
LOW:
$39.00
MEDIAN:
$61.00
CONSENSUS:
$61.00
DOWNSIDE:
9.29%
Stock News
Centene: How Paperwork Disrupted An Entire Sector
Centene offers a defensive shelter as the AI infrastructure market faces skepticism and volatility. ACA insurance exchanges suffered adverse selection as healthy individuals exited, leaving a sicker, costlier pool. Regulatory shifts and flawed industry algorithms led to unexpected losses for insurers unable to adjust patient mix.
Can Centene's Integrated Healthcare Model Support Earnings Growth?
CNC's integrated healthcare model, AI-driven operations and improving Medicaid margins are strengthening earnings as the company raises 2026 EPS guidance.
Best Growth Stocks to Buy for June 29th
CLS, CBOE, and CNC it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 29, 2026.
Best Growth Stocks to Buy for June 25th
CBOE, CNC and CRDO made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 25th, 2026.
Canada Nickel Awards Exclusive Mandate for US$600 million Investment Tax Credit Loan Facility to SB1 Markets AS
TORONTO, June 24, 2026 /PRNewswire/ - Canada Nickel Company Inc. ("Canada Nickel" or the "Company") (TSXV: CNC) (OTCQX: CNIKF) has appointed SB1 Markets AS ("SB1 Markets") as exclusive advisor to arrange debt financing of up to US$600 million. The facility would allow the Company to monetize Investment Tax Credits expected to be generated by the construction of its Crawford Nickel Project.
Health Net Providing Special Assistance to Members and Providers Affected by Palos Warehouse Fire in Los Angeles
SACRAMENTO, Calif., June 23, 2026 /PRNewswire/ -- Following Gov.
Here's Why Centene (CNC) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here Are Tuesday's Best Wall Street Analyst Research Calls: Centene, Darden Restaurants, Flutter Entertainment, GE Healthcare, IBM, Nike, SpaceX, Synopsys, Target, and More
Futures are trading lower after a mixed start to trading on Monday, following the holiday-shortened week due to the Juneteenth Federal holiday.
Best Growth Stocks to Buy for June 23rd
CBOE, CNC and CRDO made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 23rd, 2026.
CENTENE APPOINTS LAUREN M. TYLER TO BOARD OF DIRECTORS
ST. LOUIS, June 22, 2026 /PRNewswire/ -- Centene Corporation (NYSE: CNC) today announced the appointment of Lauren M. Tyler to its Board of Directors, effective June 19, 2026.
3 Medical Stocks to Bet on Amid Market Optimism Following SpaceX IPO
Medical stocks like Centene, DaVita and BrightSpring could rally as SpaceX IPO-fueled market optimism lifts broader sector sentiment.
Here's Why Centene (CNC) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Weekend Morning Brew: SpaceX's Historic IPO and Major M&A Deals
Weekly Market HighlightsDuring the week, market breadth showed a slight skew towards decliners, with 4,779 advancing stocks compared to 4,802 declining stocks.
Modesto Residents Will Gain Access to More Affordable Homes Due to $4 Million Health Net Investment
Morris Village development will expand access to long-term housing stability for families and individuals in Stanislaus County SACRAMENTO, Calif., June 18, 2026 /PRNewswire/ -- Health Net, one of California's most experienced Medi-Cal managed care health plans and company of Centene Corporation (NYSE: CNC), announced a $4 million grant award to Self-Help Enterprises to support the development of Morris Village, a new 45-unit affordable housing community located in Modesto, California.
The Healthcare M&A Wave
In this week's edition of InnovationRx, we look at biotech M&A, the rise of India's Anthem Biosciences, and more. To get it in your inbox, subscribe here.
Should Value Investors Buy Centene (CNC) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
MHS Launches Statewide Program to Help Indiana Medicaid Members with Employment
Statewide grant program applications now open for qualifying non-profit organizations that connect Medicaid members to workforce training and employment opportunities INDIANAPOLIS, June 16, 2026 /PRNewswire/ -- Managed Health Services (MHS), a managed care entity and a company of Centene Corporation (NYSE: CNC), has announced the launch of the MHS Serves Workforce Support Program, a new statewide funding opportunity designed to strengthen workforce development programs that help Medicaid members prepare for employment, increase their income and build long-term economic stability. Applications are now open through June 19, 2026 and can be submitted through the MHS Serves online portal at mhsserves.org.
Health Insurer Centene, Looking To Cut Costs, Offers Companywide Buyouts
Health insurer Centene, looking to cut costs after losing more than two million Obamacare health plan members, Monday confirmed plans to offer companywide buyouts to most employees.
Invesco's RSPH vs. PJP: Which Health Care ETF Is the Better Fund For The GLP-1 Revolution?
Compare portfolio strategies, cost structures, and risk profiles as two Invesco healthcare ETFs take different paths to sector exposure.
Price Targets
Centene price target raised to $75 from $60 at Cantor Fitzgerald
$75.00
(was $66.05)
Sarah James
·
Raymond James
Centene initiated with a Sector Perform at RBC Capital
$70.00
(was $63.67)
Ben Hendrix
·
RBC Capital
Centene price target raised to $63 from $58 at Mizuho
$63.00
(was $62.33)
Mizuho Securities
Centene price target raised to $57 from $50 at Morgan Stanley
$57.00
(was $59.55)
Erin Wright
·
Morgan Stanley
Centene price target raised to $71 from $58 at Truist
$71.00
(was $59.59)
Truist Financial
Centene price target raised to $75 from $63 at Barclays
$75.00
(was $57.65)
Barclays
Centene price target raised to $61 from $55 at UBS
$61.00
(was $57.77)
UBS
Centene price target raised to $58 from $50 at Mizuho
$58.00
(was $59.15)
Ann Hynes
·
Mizuho Securities
Centene upgraded to Buy from Hold at Deutsche Bank
$80.00
(was $59.15)
Deutsche Bank
Centene price target raised to $58 from $49 at Truist
$58.00
(was $52.69)
Truist Financial
Centene price target raised to $58 from $45 at Oppenheimer
$58.00
(was $49.57)
Oppenheimer
Centene price target raised to $40 from $32 at Goldman Sachs
$40.00
(was $49.57)
Scott Fidel
·
Goldman Sachs
Centene price target raised to $63 from $54 at Barclays
$63.00
(was $49.57)
Barclays
Cantor upgrades Centene to Overweight on margin improvement path
$60.00
(was $49.57)
Sarah James
·
Raymond James
Centene upgraded to Overweight from Neutral at Cantor Fitzgerald
$60.00
(was $49.57)
Cantor Fitzgerald
Centene price target raised to $39 from $37 at Jefferies
$39.00
(was $38.16)
David Windley
·
Jefferies
Centene (CNC) PT Lowered to $41 at Mizuho
$41.00
(was $36.40)
Ann Hynes
·
Mizuho Securities
Centene (CNC) PT Raised to $49 at Truist Securities
$49.00
(was $42.90)
Truist Financial
Centene price target raised to $44 from $43 at Wells Fargo
$44.00
(was $41.23)
Stephen Baxter
·
Wells Fargo
Centene price target raised to $39 from $32 at Deutsche Bank
$39.00
(was $39.72)
Deutsche Bank